| Name | (S)-ropivacaine hydrochloride hydrate |
|---|---|
| Synonyms |
(S)-ROPIVACAINE HCL
(2S)-N-(2,6-Dimethylphenyl)-1-propylpiperidine-2-carboxamide (S)ROPIVACAINE HYDROCHLORIDE (S)-ROPIVACAINEHYDROCHLORIDE (S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-cboxamide hydrochloride (2S)-N-(2,6-dimethylphenyl)-1-propyl-2-piperidinecboxamide hydrochloride monohydrate (-)-1-propyl-2',6'-dimethyl-2-piperidylcarboxyanilide Ropivacaine (S)ROPIVACAINE HY DROCHLORIDE 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-propyl-, (2S)-, hydrochloride, hydrate (1:1:1) S-ROPIVACAINE HCL (2S)-N-(2,6-Dimethylphenyl)-1-propyl-2-piperidinecarboxamide (S)-(-)-1-propyl-2',6'-pipecoloxylidide Ropivacaine HCl H2O IP//BP 2-Piperidinecboxamide, N-(2,6-dimethylphenyl)-1-propyl-, hydrochloride (1:1), (2S) Ropivacaine Hcl monohydrate 1-methyh-tetrazol-5-ylthiol Ropivacaine-(S) Hydrochloride Ropivacaine hydrochloride monohydrate, 10 mM in DMSO Ropivacaine Hydrochloride (S)-(-)-1-propyl-2',6'-pipecoloxylidine hydrochloride monohydrate (S)-Ropivaxaine hydrochloride (-)-1-Propyl-2',6'-pipecoloxylidide (S)-1-propyl-2',6'-dimethylanilinoformoxylpiperidine monohydrochloride monohydrate Ropivacaine HCl (mono) (S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-cboxamide hydrochloride monohydrate Ropivacaine HCl.H2O Ropivacaine HCl LEA-103 HCl (2S)-N-(2,6-Dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride hydrate (S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-cboxamide hydrochloride hydrate (S)-ROPIVACAINE HYDROCHLORIDE (2S)-N-(2,6-Dimethylphenyl)-1-propyl-2-piperidinecboxamide Hydrochloride Hydrate Ropivacaine HCI ROPIVCACAINE HYDROCHLORIDE UNII-V910P86109 Ropivacaine hydrochloride Monohydrate ROPIVACAINE HCL LEA-103 Ropivacaine (hydrochloride Monohydrate) Ropivacaini Hydrochloridum Monohydricum (+-)-ropivacaine hydrochloride (S)-ROPIVACAINEHCL S-ROPIVACAINEHCL (2S)-N-(2,6-dimethylphenyl)-1-propyl-2-Piperidinecboxamide hydrochloride hydrate (1:1:1) Ropivacaine hydrochloride Nopin Ropivacaine hydrochloride hydrate Ropivacaine hydrochloride //BP 2-Piperidinecboxamide, N-(2,6-dimethylphenyl)-1-propyl-, hydrochloride, hydrate (1:1:1), (2S) (2S)-N-(2,6-Dimethylphenyl)-1-propyl-piperidin-2-cboxamide HCl hydrate (1:1:1) Ropivacainehydrochloride l-N-n-Propylpipecolic acid-2,6-xylidide ROPIVACAINE HYDROCHLORIDE MONOHYDRATE UNII-7IO5LYA57N Ropivacaine HCl hydrate (S)-N-(2,6-dimethylphenyl)-1-propyl-2-piperidinecarboxamide (S)-1-propyl-2',6'-dimethylanilinoformoxylpiperidine,monohydrochloride,monohydrate ropivacaine hydrochloride hydrate Nopin hydrochloride monohydrate S-ROPIVACAINE HYDROCHLORIDE Ropivacaine hydrochloride (S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-cboxamide hydrochloride (2S)-N-(2,6-Dimethylphenyl)-1-propyl-2-piperidinecarboxamide hydrochloride hydrate MFCD02102164 |
| Description | Ropivacaine HCl is an anaesthetic agent and blocks impulse conduction in nerve fibres through inhibiting sodium ion influx reversibly.Target: Sodium ChannelRopivacaine is a new long-acting local anesthetic, with vasoconstrictive properties. Ropivacaine given epidurally provided adequate sensory anesthesia and motor block for transurethral surgery. Addition of epinephrine did not provide any significant prolongation of the sensory or motor block, nor any influence upon the sympathetic block [1]. Ropivacaine was metabolized to 2',6'-pipecoloxylidide (PPX), 3'-hydroxyropivacaine (3'-OH Rop), and 4'-hydroxyropivacaine (4'-OH Rop) by hepatic microsomes from human and rat. Ropivacaine N-dealkylation and 3'-hydroxylation activities correlated well with the level of CYP3A4 and 1A2 in human hepatic microsomes, respectively [2]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 410.2±45.0 °C at 760 mmHg |
| Melting Point | 267-269ºC |
| Molecular Formula | C17H29ClN2O2 |
| Molecular Weight | 328.88 |
| Flash Point | 201.9±28.7 °C |
| PSA | 41.57000 |
| LogP | 3.11 |
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
| Index of Refraction | 1.552 |
| Storage condition | Refrigerator |
| Symbol |
GHS05 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H318 |
| Precautionary Statements | P280-P305 + P351 + P338 + P310 |
| Hazard Codes | T: Toxic; |
| Risk Phrases | R26/27/28 |
| Safety Phrases | 22-36/37/39-45 |
| RIDADR | UN 2811 6.1 / PGIII |
| HS Code | 2933399090 |
|
~82%
132112-35-7 |
| Literature: Navinta LLC Patent: US2006/276654 A1, 2006 ; Location in patent: Page/Page column 5 ; |
|
~%
132112-35-7 |
| Literature: US2006/276654 A1, ; Page/Page column 5 ; |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |